File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Aggressive subcutaneous panniculitis-like T-cell lymphoma: Complete remission with fludarabine, mitoxantrone and dexamethasone

TitleAggressive subcutaneous panniculitis-like T-cell lymphoma: Complete remission with fludarabine, mitoxantrone and dexamethasone
Authors
Au, WYNg, WMChoy, CKwong, YL
KeywordsDexamethasone
Fludarabine
Mitoxantrone
Subcutaneous panniculitis-like T-cell lymphoma
Issue Date2000
PublisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJD
Citation
British Journal Of Dermatology, 2000, v. 143 n. 2, p. 408-410 How to Cite?
DOI: http://dx.doi.org/10.1046/j.1365-2133.2000.03671.x
AbstractSubcutaneous panniculitis-like T-cell lymphoma (SCPTCL) is a rare cutaneous T-cell lymphoma. The optimal treatment of this disease is undefined. A 36-year-old woman presented with swinging pyrexia, weight loss and disseminated SCPTCL involving her limbs and trunk. Typical histological features of panniculitic infiltration with rimming of fat cells and sparing of the dermis and epidermis were seen. Immunophenotyping confirmed a CD8+ cytotoxic T-cell phenotype. The patient was successfully treated with a combination of fludarabine, mitoxantrone and dexamethasone (FND), and has remained in remission 15 months after cessation of treatment. FND may be an effective regimen for aggressive SCPTCL.
Persistent Identifierhttp://hdl.handle.net/10722/162386
ISSN
0007-0963
2023 Impact Factor: 11.0
2023 SCImago Journal Rankings: 2.759
ISI Accession Number ID
WOS:000088993600028
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_US
dc.contributor.authorNg, WMen_US
dc.contributor.authorChoy, Cen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-05T05:19:29Z-
dc.date.available2012-09-05T05:19:29Z-
dc.date.issued2000en_US
dc.identifier.citationBritish Journal Of Dermatology, 2000, v. 143 n. 2, p. 408-410en_US
dc.identifier.issn0007-0963en_US
dc.identifier.urihttp://hdl.handle.net/10722/162386-
dc.description.abstractSubcutaneous panniculitis-like T-cell lymphoma (SCPTCL) is a rare cutaneous T-cell lymphoma. The optimal treatment of this disease is undefined. A 36-year-old woman presented with swinging pyrexia, weight loss and disseminated SCPTCL involving her limbs and trunk. Typical histological features of panniculitic infiltration with rimming of fat cells and sparing of the dermis and epidermis were seen. Immunophenotyping confirmed a CD8+ cytotoxic T-cell phenotype. The patient was successfully treated with a combination of fludarabine, mitoxantrone and dexamethasone (FND), and has remained in remission 15 months after cessation of treatment. FND may be an effective regimen for aggressive SCPTCL.en_US
dc.languageengen_US
dc.publisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/BJDen_US
dc.relation.ispartofBritish Journal of Dermatologyen_US
dc.rightsBritish Journal of Dermatology. Copyright © Blackwell Publishing Ltd.-
dc.subjectDexamethasone-
dc.subjectFludarabine-
dc.subjectMitoxantrone-
dc.subjectSubcutaneous panniculitis-like T-cell lymphoma-
dc.subject.meshAdulten_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Therapeutic Useen_US
dc.subject.meshDexamethasone - Administration & Dosageen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphoma, T-Cell, Cutaneous - Drug Therapy - Pathologyen_US
dc.subject.meshMitoxantrone - Administration & Dosageen_US
dc.subject.meshPanniculitis - Drug Therapy - Pathologyen_US
dc.subject.meshSkin Neoplasms - Drug Therapy - Pathologyen_US
dc.subject.meshVidarabine - Administration & Dosage - Analogs & Derivativesen_US
dc.titleAggressive subcutaneous panniculitis-like T-cell lymphoma: Complete remission with fludarabine, mitoxantrone and dexamethasoneen_US
dc.typeArticleen_US
dc.identifier.emailKwong, YL:ylkwong@hku.hken_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1046/j.1365-2133.2000.03671.xen_US
dc.identifier.pmid10951154-
dc.identifier.scopuseid_2-s2.0-0033847454en_US
dc.identifier.hkuros108036-
dc.identifier.hkuros59999-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0033847454&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume143en_US
dc.identifier.issue2en_US
dc.identifier.spage408en_US
dc.identifier.epage410en_US
dc.identifier.isiWOS:000088993600028-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridAu, WY=7202383089en_US
dc.identifier.scopusauthoridNg, WM=55138043000en_US
dc.identifier.scopusauthoridChoy, C=7202840937en_US
dc.identifier.scopusauthoridKwong, YL=7102818954en_US
dc.identifier.issnl0007-0963-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats